Streetbeat News

Analyst Ratings

AAPL

GOOG

META

NVDA

DA Davidson analyst Gil Luria initiated coverage on Meta Platforms with a Buy rating and a $600 price target, highlighting its leadership in AI and Spatial Computing. Meta is positioned as an open-source leader, contrasting with other mega-caps like Alphabet and Apple, which are focused on closed-garden platforms.

Portfolio Pulse from Anusuya Lahiri

September 10, 2024 | 6:46 pm

IREN

Deep-pocketed investors are showing a bullish trend towards Iris Energy (NASDAQ:IREN) with significant options trading activity. The stock is currently trading at $7.44, up 4.38%, and analysts have set an average target price of $15.5. The options activity suggests a focus on a price range between $2.5 and $12.5.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 6:45 pm

NKE

Deep-pocketed investors are showing a bearish trend towards Nike (NYSE:NKE) through options trading, with 52% of the activity being bearish. This unusual activity suggests potential significant movements in Nike's stock price. Analysts have mixed ratings, with price targets ranging from $79 to $93.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 6:16 pm

LBPH

Truist Securities initiated coverage on Longboard Pharmaceuticals (NASDAQ:LBPH), highlighting its high-value epilepsy assets. The company plans to advance its lead drug, bexicaserin, into Phase 3 trials. Bexicaserin has shown promising results in reducing seizures and has received FDA Breakthrough Therapy designation. Truist rates LBPH as a Buy with a $60 price target, citing bexicaserin's superior safety and potential to expand the epilepsy market.

Portfolio Pulse from Vandana Singh

September 10, 2024 | 6:13 pm

BA

The options market shows a mixed sentiment towards Boeing (NYSE:BA), with a slight bearish tilt. A significant number of unusual options trades were detected, indicating potential insider knowledge. The stock is currently trading at $158.43, down 2.75%, with a neutral RSI. Analysts have mixed ratings, with price targets ranging from $119 to $230.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 6:01 pm

INSP

Inspire Medical Systems (NYSE:INSP) has been evaluated by 7 analysts over the past three months, with a mix of bullish and bearish opinions. The average 12-month price target has decreased by 10.51% to $212.86. Analysts have adjusted their ratings and price targets in response to market conditions and company performance. Despite positive revenue growth, the company faces challenges with net margin and return on equity.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 6:00 pm

UDR

Deutsche Bank analyst Omotayo Okusanya maintains a Hold rating on UDR and raises the price target from $40 to $44.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 6:00 pm

GM

Over the past three months, 11 analysts have evaluated General Motors (NYSE:GM), with opinions ranging from bullish to bearish. The average 12-month price target is $48.0, with a high of $64.00 and a low of $32.00. Recent analyst actions include rating adjustments and price target changes, reflecting their response to market conditions and company performance. GM's financials show a solid revenue growth rate of 7.2%, a strong net margin of 6.09%, and challenges in debt management with a high debt-to-equity ratio of 1.84.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 6:00 pm

NXRT

Deutsche Bank has maintained its 'Hold' rating on NexPoint Residential (NYSE:NXRT) while raising the price target from $38 to $44.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 5:57 pm

MAA

Deutsche Bank has maintained its 'Hold' rating on Mid-America Apartment (NYSE:MAA) while raising the price target from $139 to $163.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 5:55 pm